- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.74 Å
- Oligo State
- monomer
- Ligands
- 1 x SUV: [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone(Non-covalent)
- 3 x NH4: AMMONIUM ION(Non-functional Binders)
NH4.2: 4 residues within 4Å:- Chain A: L.391, V.392, E.395
- Ligands: NH4.4
No protein-ligand interaction detected (PLIP)NH4.3: 2 residues within 4Å:- Chain A: G.266, L.391
No protein-ligand interaction detected (PLIP)NH4.4: 4 residues within 4Å:- Chain A: I.303, Y.374, E.395
- Ligands: NH4.2
No protein-ligand interaction detected (PLIP)- 21 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
OLA.5: 2 residues within 4Å:- Chain A: E.283, S.287
Ligand excluded by PLIPOLA.6: 6 residues within 4Å:- Chain A: C.168, K.260, R.264, P.388, F.389
- Ligands: OLA.15
Ligand excluded by PLIPOLA.7: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPOLA.8: 3 residues within 4Å:- Chain A: N.182, V.185, I.186
Ligand excluded by PLIPOLA.9: 2 residues within 4Å:- Chain A: S.136, K.139
Ligand excluded by PLIPOLA.10: 2 residues within 4Å:- Chain A: I.73, I.74
Ligand excluded by PLIPOLA.11: 6 residues within 4Å:- Chain A: V.480, I.483, C.484, A.523, A.527, I.530
Ligand excluded by PLIPOLA.12: 2 residues within 4Å:- Chain A: I.483, L.520
Ligand excluded by PLIPOLA.13: 2 residues within 4Å:- Chain A: S.325, K.354
Ligand excluded by PLIPOLA.14: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPOLA.15: 5 residues within 4Å:- Chain A: F.386, P.388, V.408, G.409
- Ligands: OLA.6
Ligand excluded by PLIPOLA.16: 2 residues within 4Å:- Chain A: N.533, K.544
Ligand excluded by PLIPOLA.17: 3 residues within 4Å:- Chain A: I.116, T.117, F.133
Ligand excluded by PLIPOLA.18: 6 residues within 4Å:- Chain A: I.73, F.76, P.120, L.123, V.124, T.128
Ligand excluded by PLIPOLA.19: 6 residues within 4Å:- Chain A: I.303, R.305, I.337, G.338, K.339, L.365
Ligand excluded by PLIPOLA.20: 1 residues within 4Å:- Chain A: K.139
Ligand excluded by PLIPOLA.21: 2 residues within 4Å:- Chain A: I.200, V.201
Ligand excluded by PLIPOLA.22: 3 residues within 4Å:- Chain A: L.80, I.81, V.84
Ligand excluded by PLIPOLA.23: 4 residues within 4Å:- Chain A: V.78, G.82, L.85, F.543
Ligand excluded by PLIPOLA.24: 2 residues within 4Å:- Chain A: F.258, R.472
Ligand excluded by PLIPOLA.25: 1 residues within 4Å:- Chain A: F.132
Ligand excluded by PLIP- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rappas, M. et al., Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. J.Med.Chem. (2020)
- Release Date
- 2020-01-01
- Peptides
- Orexin receptor type 2,GlgA glycogen synthase,Hypocretin receptor-2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.74 Å
- Oligo State
- monomer
- Ligands
- 1 x SUV: [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone(Non-covalent)
- 3 x NH4: AMMONIUM ION(Non-functional Binders)
- 21 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rappas, M. et al., Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. J.Med.Chem. (2020)
- Release Date
- 2020-01-01
- Peptides
- Orexin receptor type 2,GlgA glycogen synthase,Hypocretin receptor-2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
B - Membrane
-
We predict this structure to be a membrane protein.